Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.83
-0.02 (-0.34%)
Apr 9, 2026, 9:11 AM EDT - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $275.37 million as of April 9, 2026. Its market cap has increased by 67.08% in one year.
Market Cap
275.37M
Enterprise Value
191.36M
1-Year Change
67.08%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $275.37M, a decrease of -48.85%. That is a compound annual growth rate of -11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 276.32M | -3.78% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 287.04M |
| C4 Therapeutics | 282.98M |
| NovaBridge Biosciences | 282.46M |
| Protara Therapeutics | 282.32M |
| Anavex Life Sciences | 281.72M |
| Abeona Therapeutics | 277.83M |
| Polaryx Therapeutics | 271.75M |
| Editas Medicine | 270.13M |